Thoughts on BMS Joining Cellares’s Technology Adoption Partnership Program to Evaluate the Automated Production of One of Its Key CAR-Ts; Could Cellares’s Cell Shutter Become a Competitive Advantage for BMS?
Here is a brief preview of this blast: On Monday, August 28, Cellares announced (press release) that BMS joined its Technology Adoption Partnership (TAP) program, entering into a proof-of-concept transfer process for the manufacturing of one of its CAR-Ts using Cellares's proprietary Cell Shuttle platform. Below, Celltelligence provides insights into the features of Cellares's end-to-end automated process for cell therapy production while discussing the potential competitive advantage that this partnership could represent for BMS.